139 related articles for article (PubMed ID: 30325729)
41. Bcl-2 expression and prognostic significance in feline invasive mammary carcinomas: a retrospective observational study.
Dagher E; Abadie J; Loussouarn D; Fanuel D; Campone M; Nguyen F
BMC Vet Res; 2019 Jan; 15(1):25. PubMed ID: 30630524
[TBL] [Abstract][Full Text] [Related]
42. Are embryonic stem cell markers and ALDH1A1 relevant in the context of breast cancer estrogen positivity?
Mousa NA; Hussein A; Elemam NM; Mohammed G; Elwany M; Basha T; AlHammadi AA; Majzob RS; Talaat IM
Cancer Med; 2024 Feb; 13(3):e7004. PubMed ID: 38400679
[TBL] [Abstract][Full Text] [Related]
43. Interleukin 7 receptor alpha Thr244Ile genetic polymorphism is associated with susceptibility and prognostic markers in breast cancer subgroups.
Vitiello GAF; Losi Guembarovski R; Amarante MK; Ceribelli JR; Carmelo ECB; Watanabe MAE
Cytokine; 2018 Mar; 103():121-126. PubMed ID: 28964592
[TBL] [Abstract][Full Text] [Related]
44. Transcriptional expression analysis of survivin splice variants reveals differential expression of survivin-3α in breast cancer.
Moniri Javadhesari S; Gharechahi J; Hosseinpour Feizi MA; Montazeri V; Halimi M
Genet Test Mol Biomarkers; 2013 Apr; 17(4):314-20. PubMed ID: 23368531
[TBL] [Abstract][Full Text] [Related]
45. Novel targets for sensitizing breast cancer cells to TRAIL-induced apoptosis with siRNA delivery.
Thapa B; Bahadur Kc R; Uludağ H
Int J Cancer; 2018 Feb; 142(3):597-606. PubMed ID: 28960310
[TBL] [Abstract][Full Text] [Related]
46. Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer.
Lukas J; Gao DQ; Keshmeshian M; Wen WH; Tsao-Wei D; Rosenberg S; Press MF
Cancer Res; 2001 Apr; 61(7):3212-9. PubMed ID: 11306511
[TBL] [Abstract][Full Text] [Related]
47. Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER+ luminal subtypes.
Joseph C; Macnamara O; Craze M; Russell R; Provenzano E; Nolan CC; Diez-Rodriguez M; Sonbul SN; Aleskandarany MA; Green AR; Rakha EA; Ellis IO; Mukherjee A
Br J Cancer; 2018 Apr; 118(8):1142-1151. PubMed ID: 29588513
[TBL] [Abstract][Full Text] [Related]
48. Breast cancer cells response to the antineoplastic agents cisplatin, carboplatin, and doxorubicin at the mRNA expression levels of distinct apoptosis-related genes, including the new member, BCL2L12.
Thomadaki H; Scorilas A
Ann N Y Acad Sci; 2007 Jan; 1095():35-44. PubMed ID: 17404015
[TBL] [Abstract][Full Text] [Related]
49. [Expression of BCL2L12 gene in de novo acute myeloid leukemia and its clinical implications].
Yu MX; Lu Y; Mu QT; Wang Q; Chen ZM; Lou JY; Jin J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Oct; 30(5):544-8. PubMed ID: 24078567
[TBL] [Abstract][Full Text] [Related]
50. Histone acetyltransferase 1 up regulates Bcl2L12 expression in nasopharyngeal cancer cells.
Miao BP; Zhang RS; Yang G; Sun JJ; Tang YY; Liang WF; Liu T; Wen Z; Yang PC; Nie GH
Arch Biochem Biophys; 2018 May; 646():72-79. PubMed ID: 29621521
[TBL] [Abstract][Full Text] [Related]
51. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
[TBL] [Abstract][Full Text] [Related]
52. [Survival of patients with metastatic breast cancer according to pathological types of tumors].
Sánchez R C; Acevedo C F; Petric G M; Galindo A H; Domínguez C F; León R A; Razmilic V D; Ceballos C; Espinoza F; Navarro O ME; Oddó B D; Camus A M
Rev Med Chil; 2014 Apr; 142(4):428-35. PubMed ID: 25117032
[TBL] [Abstract][Full Text] [Related]
53. Distinct Tertiary Lymphoid Structure Associations and Their Prognostic Relevance in HER2 Positive and Negative Breast Cancers.
Liu X; Tsang JYS; Hlaing T; Hu J; Ni YB; Chan SK; Cheung SY; Tse GM
Oncologist; 2017 Nov; 22(11):1316-1324. PubMed ID: 28701569
[TBL] [Abstract][Full Text] [Related]
54. Triple negative breast cancer - BCL2 in prognosis and prediction. Review.
Bouchalova K; Kharaishvili G; Bouchal J; Vrbkova J; Megova M; Hlobilkova A
Curr Drug Targets; 2014; 15(12):1166-75. PubMed ID: 25374001
[TBL] [Abstract][Full Text] [Related]
55. Can expression of apoptosis genes, bcl-2 and bax, predict survival and responsiveness to chemotherapy in node-negative breast cancer patients?
Kymionis GD; Dimitrakakis CE; Konstadoulakis MM; Arzimanoglou I; Leandros E; Chalkiadakis G; Keramopoulos A; Michalas S
J Surg Res; 2001 Aug; 99(2):161-8. PubMed ID: 11469882
[TBL] [Abstract][Full Text] [Related]
56. [Bcl-2 as a prognostic factor in different molecular genetic subtypes of breast cancer].
Pavlenko IA; Povilaĭtite PE; Gorelik MZ; Petrov AV
Arkh Patol; 2012; 74(5):36-40. PubMed ID: 23342658
[TBL] [Abstract][Full Text] [Related]
57. The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes.
El Ansari R; Craze ML; Diez-Rodriguez M; Nolan CC; Ellis IO; Rakha EA; Green AR
Br J Cancer; 2018 Apr; 118(8):1115-1122. PubMed ID: 29545595
[TBL] [Abstract][Full Text] [Related]
58. Association of osteopontin with specific prognostic factors and survival in adjuvant breast cancer trials of the Hellenic Cooperative Oncology Group.
Psyrri A; Kalogeras KT; Wirtz RM; Kouvatseas G; Karayannopoulou G; Goussia A; Zagouri F; Veltrup E; Timotheadou E; Gogas H; Koutras A; Lazaridis G; Christodoulou C; Pentheroudakis G; Economopoulou P; Laskarakis A; Arapantoni-Dadioti P; Batistatou A; Sotiropoulou M; Aravantinos G; Papakostas P; Kosmidis P; Pectasides D; Fountzilas G
J Transl Med; 2017 Feb; 15(1):30. PubMed ID: 28193231
[TBL] [Abstract][Full Text] [Related]
59. The impact of CBP expression in estrogen receptor-positive breast cancer.
Ramadan WS; Talaat IM; Hachim MY; Lischka A; Gemoll T; El-Awady R
Clin Epigenetics; 2021 Apr; 13(1):72. PubMed ID: 33827682
[TBL] [Abstract][Full Text] [Related]
60. MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer.
Han J; Choi YL; Kim H; Choi JY; Lee SK; Lee JE; Choi JS; Park S; Choi JS; Kim YD; Nam SJ; Nam BH; Kwon MJ; Shin YK
Breast Cancer Res Treat; 2017 Jul; 164(1):41-56. PubMed ID: 28409241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
